Related Experiment Videos
Simultaneous pancreas-kidney transplantation is improved by living kidney donation program
U Boggi1, A Pietrabissa, F Vistoli
1Tuscany Region Referral Center for Treatment of Pancreatic Diseases, Pisa, Italy.
Transplantation Proceedings
|June 15, 2004
Summary
Living kidney donation (LKD) significantly expands the donor pool for simultaneous pancreas-kidney transplantation (SPKTx). This approach reduces waiting times and increases graft access for diabetic recipients awaiting transplants.
Area of Science:
- Transplantation immunology
- Organ donation and procurement
- Diabetic nephropathy management
Background:
- Cadaveric kidney shortages and allocation priorities limit access for diabetic recipients.
- Living kidney donation (LKD) combined with cadaveric pancreas offers an alternative to simultaneous pancreas-kidney transplantation (SPKTx).
Purpose of the Study:
- To evaluate the impact of LKD on expanding the donor pool for SPKTx.
- To assess the effect of LKD on reducing waiting times for SPKTx recipients.
- To compare outcomes of simultaneous cadaveric pancreas-living kidney transplantation (SPLKTx) with SPKTx.
Main Methods:
- Enrolled 80 recipients on the SPKTx waiting list between June 2001 and June 2003.
- Counseled recipients' families regarding LKD; 29 evaluated, 21 scheduled, and 18 completed LKD.
- Compared waiting times and transplantation rates with and without LKD.
Main Results:
- LKD increased the donor pool by 18, expanding it from 33 to 51 recipients (P =.004).
- Median waiting time for SPLKTx was 14 days vs. 95 days for SPKTx (P =.006).
- One-year graft rates were 60% with LKD vs. 42% without (P =.01); two-year survival rates were comparable.
Conclusions:
- LKD effectively expands the kidney donor pool and reduces waiting times for SPKTx.
- SPLKTx increases timely graft access for recipients on the waiting list.
- One-year outcomes for SPLKTx are equivalent to those of SPKTx.